Aldosterone Blockade in Patients With Systolic Left Ventricular Dysfunction

This publication has 18 references indexed in Scilit:

• Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthesis in Patients With First Anterior Acute Myocardial Infarction
  Circulation, 2003
• Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 2003
• Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines
  Published by Elsevier ,2003
• Clinical implications of aldosterone blockade
  American Heart Journal, 2002
• Pathophysiological effects of aldosterone in cardiovascular tissues
  Trends in Endocrinology & Metabolism, 2001
• Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases
  The American Journal of Medicine, 2001
• Serious adverse events experienced by patients with chronic heart failure taking spironolactone
  Heart, 2001
• Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction
  American Heart Journal, 2001
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension
  JAMA, 1991